Celldex Therapeutics, Inc.
DE ˙ DB ˙ US15117B2025
25,28 € ↑0,78 (3,18%)
2026-06-04
AKTIENPREIS
SecurityDE:TCE2 / Celldex Therapeutics, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership1,253,532 shares
Latest Disclosed Value $ 39,762,035
Millennium Management Llc ownership in TCE2 / Celldex Therapeutics, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 1,253,532 shares of Celldex Therapeutics, Inc. (DE:TCE2) valued at $32,090,419 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,212,705 shares of Celldex Therapeutics, Inc.. This represents a change in shares of 3.37% during the quarter. The current value of the position is $31,689,289 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (TCE2) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:TCE2 / Celldex Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 1,253,532 40,827 3.37 39,762 20.72 0.0165
2026-02-17 2025-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 1,212,705 237,510 24.36 32,937 30.56 0.0139
2025-11-14 2025-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 975,195 497,968 104.35 25,228 159.79 0.0108
2025-08-14 2025-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 477,227 77,295 19.33 9,712 33.80 0.0047
2025-05-15 2025-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 399,932 306,330 327.27 7,259 206.89 0.0039
2025-02-14 2024-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 93,602 -14,501 -13.41 2,365 -35.63 0.0012
2024-11-14 2024-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 108,103 64,353 147.09 3,674 126.93 0.0017
2024-08-14 2024-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 43,750 -164,501 -78.99 1,619 -81.48 0.0007
2024-05-15 2024-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 208,251 197,254 1,793.71 8,740 1,904.59 0.0037
2024-02-14 2023-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 10,997 -147,160 -93.05 436 -89.98 0.0002
2023-11-14 2023-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 158,157 137,417 662.57 4,352 519.06 0.0022
2023-08-14 2023-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 20,740 20,740 704 0.0003
2023-05-15 2023-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 0 -34,351 -100.00 0 -100.00
2023-02-14 2022-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 34,351 34,351 1,531 0.0008
2022-11-14 2022-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 0 -143,343 -100.00 0 -100.00
2022-08-15 2022-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 143,343 35,642 33.09 3,865 5.37 0.0024
2022-05-16 2022-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 107,701 68,030 171.49 3,668 139.27 0.0019
2022-02-14 2021-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 39,671 39,671 1,533 0.0008
2021-08-16 2021-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 0 -505,163 -100.00 0 -100.00
2021-05-17 2021-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 505,163 299,241 145.32 10,406 188.41 0.0074
2021-02-16 2020-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 205,922 205,922 3,608 0.0026
2020-11-16 2020-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 0 -430,564 -100.00 0 -100.00
2020-08-14 2020-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 430,564 430,564 5,597 0.0077
2019-05-14 2019-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 0 -379,382 -100.00 0 -100.00
2019-02-15 2018-12-31 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B103 379,382 -1,447,866 -79.24 75 -90.90 0.0001
2019-02-14 2018-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 379,382 75
2018-11-14 2018-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 1,827,248 -350,702 -16.10 824 -24.89 0.0010
2018-08-14 2018-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 2,177,950 273,066 14.34 1,097 -75.28 0.0014
2018-05-15 2018-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 1,904,884 -336,637 -15.02 4,438 -30.29 0.0059
2018-02-14 2017-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 2,241,521 400,965 21.78 6,366 20.93 0.0088
2017-11-14 2017-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 1,840,556 1,685,775 1,089.14 5,264 1,278.01 0.0080
2017-08-14 2017-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 154,781 86,471 126.59 382 54.66 0.0007
2017-05-15 2017-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 68,310 -916,794 -93.07 247 -92.92 0.0005
2017-02-14 2016-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 985,104 298,049 43.38 3,487 25.61 0.0073
2016-11-14 2016-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 687,055 468,148 213.86 2,776 188.87 0.0047
2016-08-15 2016-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 218,907 -2,331,640 -91.42 961 -90.03 0.0022
2016-05-16 2016-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 2,550,547 2,241,148 724.36 9,641 98.74 0.0241
2016-02-16 2015-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 309,399 -454,944 -59.52 4,851 -39.78 0.0102
2015-11-16 2015-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 764,343 210,870 38.10 8,056 -42.29 0.0156
2015-08-14 2015-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 553,473 -1,516,994 -73.27 13,959 -75.81 0.0264
2015-05-15 2015-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 2,070,467 1,992,203 2,545.49 57,704 3,940.90 0.1074
2015-02-17 2014-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 78,264 67,464 624.67 1,428 920.00 0.0030
2014-11-14 2014-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 10,800 10,800 0.00 140 0.0004
2014-08-14 2014-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 0 -259,900 -100.00 0 -100.00
2014-05-15 2014-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 259,900 248,300 2,140.52 4,592 1,534.16 0.0133
2014-02-14 2013-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 11,600 -204,702 -94.64 281 -96.33 0.0009
2013-11-14 2013-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 216,302 -18,951 -8.06 7,664 108.71 0.0247
2013-08-14 2013-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 235,253 235,253 3,672 0.0113
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-14 2024-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 30,000 1,020 n/a n/a n/a
2023-05-15 2023-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 20,000 891 n/a n/a n/a
2020-11-16 2020-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 31,200 406 n/a n/a n/a
2018-08-14 2018-06-30 13F CELLDEX THERAPEUTICS INC COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F CELLDEX THERAPEUTICS INC COM Call 250,000 583 n/a n/a n/a
2014-08-14 2014-06-30 13F CELLDEX THERAPEUTICS INC COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-05-15 2014-03-31 13F CELLDEX THERAPEUTICS INC COM Call 81,900 -14.86 1,447 -37.87 n/a n/a n/a
2014-02-14 2013-12-31 13F CELLDEX THERAPEUTICS INC COM Call 96,200 2,329 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-14 2024-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 21,400 727 n/a n/a n/a
2022-11-14 2022-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 116,200 3,133 n/a n/a n/a
2014-05-15 2014-03-31 13F CELLDEX THERAPEUTICS INC COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-02-14 2013-12-31 13F CELLDEX THERAPEUTICS INC COM Put 35,000 847 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.